Literature DB >> 25254356

Intra-aortic balloon counterpulsation reduces mortality in large anterior myocardial infarction complicated by persistent ischaemia: a CRISP-AMI substudy.

Lokien X van Nunen1, Marcel van 't Veer, Stéphanie Schampaert, Marcel C M Rutten, Frans N van de Vosse, Manesh R Patel, Nico H J Pijls.   

Abstract

AIMS: This substudy investigated IABP support in large STEMI complicated by persistent ischaemia within the original CRISP-AMI trial. METHODS AND
RESULTS: Patients were included if the ECG at admission showed summed ST deviation (ST-D) ≥15 mm and the ECG post PCI showed poor ST resolution (<50%). Endpoints evaluated were all-cause mortality at six months and the composite endpoint of death, cardiogenic shock or new or worsening heart failure at six months. One hundred and forty-nine patients had ST-D ≥15 mm (mean ST-D 24±8 mm). Of these patients, 36 (24%) showed poor ST resolution (15 patients in the IABP group; 21 patients in the control group). Mean age was 55±11 years, 89% were male. Mean systolic and diastolic blood pressures were 135±31 mmHg and 83±22 mmHg, respectively. The left anterior descending coronary artery was the infarct-related artery in all cases, primary PCI was successful in 94%. At six months, zero patients in the IABP group died versus five patients in the control group (0% versus 24%; p=0.046). There was a trend towards statistical significance in the composite endpoint (one patient [7%] versus seven patients [33%]; p=0.06).
CONCLUSIONS: In this substudy, use of IABP was associated with decreased six-month mortality in large STEMI complicated by persistent ischaemia after PCI.

Entities:  

Mesh:

Year:  2015        PMID: 25254356     DOI: 10.4244/EIJY14M09_10

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  5 in total

1.  Initiation of Intra-Aortic Balloon Counterpulsation before Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction and High-Risk Features Might be Beneficial: Questions Remain.

Authors:  Hung-Ju Lin; Tzung-Dau Wang
Journal:  Acta Cardiol Sin       Date:  2017-11       Impact factor: 2.672

2.  Predictors of mortality in patients with cardiogenic shock treated with primary percutaneous coronary intervention and intra-aortic balloon counterpulsation.

Authors:  B Schwarz; M Abdel-Wahab; D R Robinson; G Richardt
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-11-23       Impact factor: 0.840

3.  Benefits of Intraaortic Balloon Support for Myocardial Infarction Patients in Severe Cardiogenic Shock Undergoing Coronary Revascularization.

Authors:  Chun-Tai Mao; Jian-Liang Wang; Dong-Yi Chen; Ming-Lung Tsai; Yu-Sheng Lin; Wen-Jin Cherng; Chao-Hung Wang; Ming-Shien Wen; I-Chang Hsieh; Ming-Jui Hung; Chun-Chi Chen; Tien-Hsing Chen
Journal:  PLoS One       Date:  2016-08-02       Impact factor: 3.240

4.  Intra-aortic Balloon Counterpulsation for High-Risk Percutaneous Coronary Intervention: Defining Coronary Responders.

Authors:  Natalia Briceno; Kalpa De Silva; Matthew Ryan; Tiffany Patterson; Kevin O'Gallagher; Howard Ellis; Simone Rivolo; Jack Lee; Simon Redwood; Ajay M Shah; Michael Marber; Divaka Perera
Journal:  J Cardiovasc Transl Res       Date:  2019-03-15       Impact factor: 4.132

Review 5.  Ischemia Reperfusion Injury: Mechanisms of Damage/Protection and Novel Strategies for Cardiac Recovery/Regeneration.

Authors:  Andrea Caccioppo; Luca Franchin; Alberto Grosso; Filippo Angelini; Fabrizio D'Ascenzo; Maria Felice Brizzi
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.